World Journal of
Pharmaceutical and Life Sciences

A BRIEF REPORT ON COMORBIDITIES AND RISK FACTORS OF COVID-19 (SARS-COV-2) PATIENTS

Mohammed Farhan Qureshi* and Shoeb Qureshi

ABSTRACT

Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) caused over 3 million infections and over 250,000 deaths worldwide 2 months after the World Health Organization declared the virus-induced disease a pandemic. Certain comorbidities and risk factors have shown increased susceptibility and disease severity. Earlier reports suggested that elderly patients with comorbidities, particularly diabetes, cardiovascular disease, renal insufficiency, obesity and hypertension, suffered greater mortality than younger patients. In addition to the comorbidities, there are certain risk factors (age, sex, race, ethnicity and genetics) which further deteriorate the condition of Covid-19 patients. Hence a review of literature on the impact of comorbidities and risk factors on Coronavirus 2 was of profound interest. An electronic search was conducted in Lit Covid, PubMed, Google Scholar, WHO, and Centers for Disease Control and Prevention databases. Search terms included COVID-19, SARS-CoV-2, comorbidities and risk factors. Manuscripts published were reviewed; relevant references were checked before making this report on the comorbidities and risk factors of Covid-19.

[Full Text Article]   [Download Certificate]